Department of Epizootiology, Parasitology and Protection of One Health, University of Veterinary Medicine and Pharmacy in KošiceKošice, Slovak Republic
This work is licensed under the Creative Commons Attribution 4.0 International License.
Abdelmegeed S.M., Mohammed S.: Canine mammary tumors as a model for human disease. Oncol Lett 2018, 15, 8195–8205, doi: 10.3892/ol.2018.8411.AbdelmegeedS.M.MohammedS.: Canine mammary tumors as a model for human disease. Oncol Lett2018, 15, 8195–8205, doi: 10.3892/ol.2018.8411.Open DOISearch in Google Scholar
Baba A.I., Câtoi C.: Chapter 11 Mammary Gland Tumors. In: Comparative Oncology. The Publishing House of the Romanian Academy, Bucharest, Romania, 2007.BabaA.I.CâtoiC.: Chapter 11 Mammary Gland Tumors. In: Comparative Oncology. The Publishing House of the Romanian Academy, Bucharest, Romania, 2007.Search in Google Scholar
Barak V., Goike H., Panaretakis K.W., Einarsson R.: Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004, 37, 529–540, doi: 10.1016/j.clinbiochem.2004.05.009.BarakV.GoikeH.PanaretakisK.W.EinarssonR.: Clinical utility of cytokeratins as tumor markers. Clin Biochem2004, 37, 529–540, doi: 10.1016/j.clinbiochem.2004.05.009.Open DOISearch in Google Scholar
Benavente M.A., Bianchi C.P., Aba M.A.: Canine Mammary Tumors: Risk Factors, Prognosis and Treatments. J Vet Adv 2016, 6, 1291–1300, doi: 10.5455/jva.20160916045115.BenaventeM.A.BianchiC.P.AbaM.A.: Canine Mammary Tumors: Risk Factors, Prognosis and Treatments. J Vet Adv2016, 6, 1291–1300, doi: 10.5455/jva.20160916045115.Open DOISearch in Google Scholar
Brunetti B., Bacci B., Angeli C., Benazzi C., Muscatello L.V.: p53, ER, and Ki67 Expression in Canine Mammary Carcinomas and Correlation With Pathological Variables and Prognosis. Vet Pathol 2021, 58, 325–331, doi: 10.1177/0300985820973462.BrunettiB.BacciB.AngeliC.BenazziC.MuscatelloL.V.: p53, ER, and Ki67 Expression in Canine Mammary Carcinomas and Correlation With Pathological Variables and Prognosis. Vet Pathol2021, 58, 325–331, doi: 10.1177/0300985820973462.Open DOISearch in Google Scholar
Caceres S., Peña L., de Andres P.J., Illera M.J., Lopez M.S., Woodward W.A., Reuben J.M.: Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. PLoS One 2015, 10, e0122277, doi: 10.1371/journal.pone.0122277.CaceresS.PeñaL.de AndresP.J.IlleraM.J.LopezM.S.WoodwardW.A.ReubenJ.M.: Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. PLoS One2015, 10, e0122277, doi: 10.1371/journal.pone.0122277.Open DOISearch in Google Scholar
Chen A., Ye S., Zheng J., Li J., Chen Z., Zhang Y., Li S.: Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line. BMC Vet Res 2023, 19, 22, doi: 10.1186/s12917-023-03573-9.ChenA.YeS.ZhengJ.LiJ.ChenZ.ZhangY.LiS.: Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line. BMC Vet Res2023, 19, 22, doi: 10.1186/s12917-023-03573-9.Open DOISearch in Google Scholar
Davis B.W., Ostrander E.A.: Domestic Dogs and Cancer Research: A Breed-Based Genomics Approach. ILAR J 2014, 55, 59–68, doi: 10.1093/ilar/ilu017.DavisB.W.OstranderE.A.: Domestic Dogs and Cancer Research: A Breed-Based Genomics Approach. ILAR J2014, 55, 59–68, doi: 10.1093/ilar/ilu017.Open DOISearch in Google Scholar
de Oliveira J.T., Pinho S.S., de Matos A.J., Hespanhol V., Reis C.A., Gärtner, F.: MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features. Vet J 2009, 182, 491–493, doi: 10.1016/j.tvjl.2008.09.007.de OliveiraJ.T.PinhoS.S.de MatosA.J.HespanholV.ReisC.A.GärtnerF.: MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features. Vet J2009, 182, 491–493, doi: 10.1016/j.tvjl.2008.09.007.Open DOISearch in Google Scholar
Dominguez P.A., Dervisis N.G., Cadile C.D., Sarbu L., Kitchell B.E.: Combined gemcitabine and carboplatin therapy for carcinomas in dogs. J Vet Intern Med 2009, 23, 130–137, doi: 10.1111/j.1939-1676.2008.0248.x.DominguezP.A.DervisisN.G.CadileC.D.SarbuL.KitchellB.E.: Combined gemcitabine and carboplatin therapy for carcinomas in dogs. J Vet Intern Med2009, 23, 130–137, doi: 10.1111/j.1939-1676.2008.0248.x.Open DOISearch in Google Scholar
Gao H., Zhou H., Gao Y., He L., Li W., Xu M., Feng H., Feng X., Qui Ch.: Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118. Vet Comp Oncol 2022, 20, 679–687, doi: 10.1111/vco.12822.GaoH.ZhouH.GaoY.HeL.LiW.XuM.FengH.FengX.QuiCh.: Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118. Vet Comp Oncol2022, 20, 679–687, doi: 10.1111/vco.12822.Open DOISearch in Google Scholar
Guillen-Poza P.A., Sánchez-Fernández E.M., Artigas G., García Fernández J.M., Hinou H., Mellet C.O., Nishimura S.-I., Garcia-Martin F.: Amplified detection of breast cancer autoantibodies using MUC1-based Tn antigen mimics. J Med Chem 2020, 63, 8524–8533, doi: 10.1021/acs.jmedchem.0c00908.Guillen-PozaP.A.Sánchez-FernándezE.M.ArtigasG.García FernándezJ.M.HinouH.MelletC.O.NishimuraS.-I.Garcia-MartinF.: Amplified detection of breast cancer autoantibodies using MUC1-based Tn antigen mimics. J Med Chem2020, 63, 8524–8533, doi: 10.1021/acs.jmedchem.0c00908.Open DOISearch in Google Scholar
Hashmi A.A., Naz S., Hashmi S.K., Hussain Z.F., Irfan M., Abu Bakar S.M., Faridi N., Khan A., Edhi M.M.: Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population. BMC Res Notes 2018, 11, 372, doi: 10.1186/s13104-018-3477-4.HashmiA.A.NazS.HashmiS.K.HussainZ.F.IrfanM.Abu BakarS.M.FaridiN.KhanA.EdhiM.M.: Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population. BMC Res Notes2018, 11, 372, doi: 10.1186/s13104-018-3477-4.Open DOISearch in Google Scholar
Henry C.J.: Biomarkers in veterinary cancer screening: Applications, limitations and expectations. Vet J 2010, 185, 10–14, doi: 10.1016/j.tvjl.2010.04.005.HenryC.J.: Biomarkers in veterinary cancer screening: Applications, limitations and expectations. Vet J2010, 185, 10–14, doi: 10.1016/j.tvjl.2010.04.005.Open DOISearch in Google Scholar
Kaszak I., Ruszczak A., Kanafa S., Kacprzak K., Król M., Jurka P.: Current biomarkers of canine mammary tumors. Acta Vet Scand 2018, 60, 66, doi: 10.1186/s13028-018-0417-1.KaszakI.RuszczakA.KanafaS.KacprzakK.KrólM.JurkaP.: Current biomarkers of canine mammary tumors. Acta Vet Scand2018, 60, 66, doi: 10.1186/s13028-018-0417-1.Open DOISearch in Google Scholar
Król M., Pawłowski K.M., Szyszko K., Maciejewski H., Dolka I., Manuali E., Jank M., Motyl T.: The gene expression profiles of canine mammary cancer cells grown with carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro. BMC Vet Res 2012, 8, 35, doi: 10.1186/1746-6148-8-35.KrólM.PawłowskiK.M.SzyszkoK.MaciejewskiH.DolkaI.ManualiE.JankM.MotylT.: The gene expression profiles of canine mammary cancer cells grown with carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro. BMC Vet Res2012, 8, 35, doi: 10.1186/1746-6148-8-35.Open DOISearch in Google Scholar
Lainetti P. de F., Brandi A., Leis Filho A.F., Prado M.C.M., Kobayashi P.E., Laufer-Amorim R., Fonseca-Alves C.E.: Establishment and characterization of canine mammary gland carcinoma cell lines with vasculogenic mimicry ability in vitro and in vivo. Front Vet Sci 2020, 7, 583874, doi: 10.3389/fvets.2020.583874.LainettiP.deF.BrandiA.Leis FilhoA.F.PradoM.C.M.KobayashiP.E.Laufer-AmorimR.Fonseca-AlvesC.E.: Establishment and characterization of canine mammary gland carcinoma cell lines with vasculogenic mimicry ability in vitro and in vivo. Front Vet Sci2020, 7, 583874, doi: 10.3389/fvets.2020.583874.Open DOISearch in Google Scholar
Li R., Wu H., Sun Y., Zhu J., Tang J., Kuang Y., Li G.: A novel canine mammary cancer cell line: preliminary identification and utilization for drug screening studies. Front Vet Sci 2021, 8, 665906, doi: 10.3389/fvets.2021.665906.LiR.WuH.SunY.ZhuJ.TangJ.KuangY.LiG.: A novel canine mammary cancer cell line: preliminary identification and utilization for drug screening studies. Front Vet Sci2021, 8, 665906, doi: 10.3389/fvets.2021.665906.Open DOISearch in Google Scholar
Liu Y., Hu T., Shen J., Li S.F., Lin J.W., Zheng X.H., Gao Q.H., Zhou H.M.: Separation, cultivation and biological characteristics of oral carcinoma-associated fibroblasts. Oral Dis 2006, 12, 375–380, doi: 10.1111/j.1601-0825.2005.01207.x.LiuY.HuT.ShenJ.LiS.F.LinJ.W.ZhengX.H.GaoQ.H.ZhouH.M.: Separation, cultivation and biological characteristics of oral carcinoma-associated fibroblasts. Oral Dis2006, 12, 375–380, doi: 10.1111/j.1601-0825.2005.01207.x.Open DOISearch in Google Scholar
Manuali E., De Giuseppe A., Feliziani F., Forti K., Casciari C., Marchesi M.Ch., Pacifico E., Pawłowski K.M., Majchrzak K., Król M.: CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Vet Res 2012, 8, 86, doi: 10.1186/1746-6148-8-86.ManualiE.De GiuseppeA.FelizianiF.FortiK.CasciariC.MarchesiM.Ch.PacificoE.PawłowskiK.M.MajchrzakK.KrólM.: CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade. BMC Vet Res2012, 8, 86, doi: 10.1186/1746-6148-8-86.Open DOISearch in Google Scholar
Marchesi M., Manuali E., Pacifico E., Ferri C., Romagnoli M., Mangili V., Fruganti G.: Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study. Vet Res Commun 2010, 34, 103–106, doi: 10.1007/s11259-010-9392-3.MarchesiM.ManualiE.PacificoE.FerriC.RomagnoliM.MangiliV.FrugantiG.: Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study. Vet Res Commun2010, 34, 103–106, doi: 10.1007/s11259-010-9392-3.Open DOISearch in Google Scholar
Mei C., Xin L., Liu Y., Lin J., Xian H., Zhang X., Hu W., Xia Z., Wang H., Lyu Y.: Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026. Front Vet Sci 2021, 8, 744032, doi: 10.3389/fvets.2021.744032.MeiC.XinL.LiuY.LinJ.XianH.ZhangX.HuW.XiaZ.WangH.LyuY.: Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026. Front Vet Sci2021, 8, 744032, doi: 10.3389/fvets.2021.744032.Open DOISearch in Google Scholar
Misdorp W.: Volume 7, Histological classification of mammary tumors of the dog and the cat. In: International Histological Classification of Domestic Animals, Second Series, Armed Forces Institute of Pathology, American Registry of Pathology, World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, D.C., 1999.MisdorpW.: Volume 7, Histological classification of mammary tumors of the dog and the cat. In: International Histological Classification of Domestic Animals, Second Series, Armed Forces Institute of Pathology, American Registry of Pathology, World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, D.C., 1999.Search in Google Scholar
Muniappan N., Ramesh S., Hemalatha S., Shafiuzama M., Preetha S.P.: Expression of Biomarkers in Canine Mammary Tumours. Int J Curr Microbiol App Sci 2019, 8, 1464–1473, doi: 10.20546/ijcmas.2019.805.168.MuniappanN.RameshS.HemalathaS.ShafiuzamaM.PreethaS.P.: Expression of Biomarkers in Canine Mammary Tumours. Int J Curr Microbiol App Sci2019, 8, 1464–1473, doi: 10.20546/ijcmas.2019.805.168.Open DOISearch in Google Scholar
Nguyen F., Peña L., Ibisch C., Loussouarn D., Gama A., Rieder N., Belousov A., Campone M., Abadie J.: Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Breast Cancer Res Treat 2018, 167, 635–648, doi: 10.1007/s10549-017-4548-2.NguyenF.PeñaL.IbischC.LoussouarnD.GamaA.RiederN.BelousovA.CamponeM.AbadieJ.: Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Breast Cancer Res Treat2018, 167, 635–648, doi: 10.1007/s10549-017-4548-2.Open DOISearch in Google Scholar
Nowak M., Madej J.A., Pula B., Dzięgiel P., Ciaputa R.: Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas. Ir Vet J 2016, 69, 9, doi: 10.1186/s13620-016-0068-3.NowakM.MadejJ.A.PulaB.DzięgielP.CiaputaR.: Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas. Ir Vet J2016, 69, 9, doi: 10.1186/s13620-016-0068-3.Open DOISearch in Google Scholar
Peña L.L., Nieto A.I., Pérez-Alenza D., Cuesta P., Castaño M.: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest 1998, 10, 237–246, doi: 10.1177/104063879801000303.PeñaL.L.NietoA.I.Pérez-AlenzaD.CuestaP.CastañoM.: Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest1998, 10, 237–246, doi: 10.1177/104063879801000303.Open DOISearch in Google Scholar
Rasotto R., Goldschmidt M.H., Castagnaro M., Carnier P., Caliari D., Zappulli V.: The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis. J Comp Pathol 2014, 151, 166–180, doi: 10.1016/j.jcpa.2014.04.013.RasottoR.GoldschmidtM.H.CastagnaroM.CarnierP.CaliariD.ZappulliV.: The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis. J Comp Pathol2014, 151, 166–180, doi: 10.1016/j.jcpa.2014.04.013.Open DOISearch in Google Scholar
Rezaie A., Tavasoli A., Mehrazma M., Bahonar A.: Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma. Comp Clin Path 2010, 20, 557–561, doi: 10.1007/s00580-010-1032-3.RezaieA.TavasoliA.MehrazmaM.BahonarA.: Immuno-histochemical staining expression of Ki67 protein in canine mammary gland carcinoma. Comp Clin Path2010, 20, 557–561, doi: 10.1007/s00580-010-1032-3.Open DOISearch in Google Scholar
Richter M., Piwocka O., Musielak M., Piotrowski I., Suchorska W.M., Trzeciak T.: From donor to the lab: a fascinating journey of primary cell lines. Front Cell Dev Biol 2021, 9, 711381, doi: 10.3389/fcell.2021.711381.RichterM.PiwockaO.MusielakM.PiotrowskiI.SuchorskaW.M.TrzeciakT.: From donor to the lab: a fascinating journey of primary cell lines. Front Cell Dev Biol2021, 9, 711381, doi: 10.3389/fcell.2021.711381.Open DOISearch in Google Scholar
Sammarco A., Gomiero C., Beffagna G., Cavicchioli L., Ferro S., Michieletto S., Orvieto E., Patruno M., Zappulli V.: Epithelial-to-mesenchymal transition and phenotypic marker evaluation in human, canine, and feline mammary gland tumors. Animals 2023, 13, 878, doi: 10.3390/ani13050878.SammarcoA.GomieroC.BeffagnaG.CavicchioliL.FerroS.MichielettoS.OrvietoE.PatrunoM.ZappulliV.: Epithelial-to-mesenchymal transition and phenotypic marker evaluation in human, canine, and feline mammary gland tumors. Animals2023, 13, 878, doi: 10.3390/ani13050878.Open DOISearch in Google Scholar
Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.-Y., White D.J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A.: Fiji: an open-source platform for biological-image analysis. Nat Methods 2012, 9, 676–682, doi: 10.1038/nmeth.2019.SchindelinJ.Arganda-CarrerasI.FriseE.KaynigV.LongairM.PietzschT.PreibischS.RuedenC.SaalfeldS.SchmidB.TinevezJ.-Y.WhiteD.J.HartensteinV.EliceiriK.TomancakP.CardonaA.: Fiji: an open-source platform for biological-image analysis. Nat Methods2012, 9, 676–682, doi: 10.1038/nmeth.2019.Open DOISearch in Google Scholar
Sorenmo K.U., Worley D.R., Zappulli V.: Tumors of the Mammary Gland. In: Withrow and MacEwen’s Small Animal Clinical Oncology, Sixth Edition, edited by D.M. Vail, D.H. Thamm, J.M. Liptak. W.B. Saunders, St. Louis, MO, USA, 2019, pp 604-625.SorenmoK.U.WorleyD.R.ZappulliV.: Tumors of the Mammary Gland. In: Withrow and MacEwen’s Small Animal Clinical Oncology, Sixth Edition, edited by VailD.M.ThammD.H.LiptakJ.M.. W.B. Saunders, St. Louis, MO, USA, 2019, pp 604–625.Search in Google Scholar
Stephens T.: The use of chemotherapy to prolong the life of dogs suffering from cancer: the ethical dilemma. Animals 2019, 9, 441, doi: 10.3390/ani9070441.StephensT.: The use of chemotherapy to prolong the life of dogs suffering from cancer: the ethical dilemma. Animals2019, 9, 441, doi: 10.3390/ani9070441.Open DOISearch in Google Scholar
Tran C.M., Moore A.S., Frimberger A.E.: Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol 2016, 14, 252–262, doi: 10.1111/vco.12092.TranC.M.MooreA.S.FrimbergerA.E.: Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol2016, 14, 252–262, doi: 10.1111/vco.12092.Open DOISearch in Google Scholar
Zhang H., Pei S., Zhou B., Wang H., Du H., Zhang D., Lin D.: Establishment and characterization of a new triple-negative canine mammary cancer cell line. Tissue Cell 2018, 54, 10–19, doi: 10.1016/j.tice.2018.07.003.ZhangH.PeiS.ZhouB.WangH.DuH.ZhangD.LinD.: Establishment and characterization of a new triple-negative canine mammary cancer cell line. Tissue Cell2018, 54, 10–19, doi: 10.1016/j.tice.2018.07.003.Open DOISearch in Google Scholar
Zhao Y., Lin Z., Lin Z., Zhou Ch., Liu G., Lin J., Zhang D., Lin D.: Overexpression of mucin 1 suppresses the therapeutical efficacy of disulfiram against canine mammary tumor. Animals 2021, 11, 37, doi: 10.3390/ani11010037.ZhaoY.LinZ.LinZ.ZhouCh.LiuG.LinJ.ZhangD.LinD.: Overexpression of mucin 1 suppresses the therapeutical efficacy of disulfiram against canine mammary tumor. Animals2021, 11, 37, doi: 10.3390/ani11010037.Open DOISearch in Google Scholar
Zhou B., Chen W.-L., Wang Y.-Y., Lin Z.-Y., Zhang D.-M., Fan S., Li J.-S.: A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. J Oral Pathol Med 2014, 43, 585–592, doi: 10.1111/jop.12172.ZhouB.ChenW.-L.WangY.-Y.LinZ.-Y.ZhangD.-M.FanS.LiJ.-S.: A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. J Oral Pathol Med2014, 43, 585–592, doi: 10.1111/jop.12172.Open DOISearch in Google Scholar
Zuccari D.A.P.C., Santana A.E., Cury P.M., Cordeiro J.A.: Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Vet Clin Pathol 2004, 33, 23–28, doi 10.1111/j.1939-165X.2004.tb00345.x.ZuccariD.A.P.C.SantanaA.E.CuryP.M.CordeiroJ.A.: Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Vet Clin Pathol2004, 33, 23–28, doi 10.1111/j.1939-165X.2004.tb00345.x.Open DOISearch in Google Scholar